Concepedia

Kimberly Loo

KL

Statistics

Publications

8

Citations

2.3K

H-Index

8

Active since

2009

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Angeles Clinic and Research Institute

University Hospital of Zurich

UCLA Health

Kimberly Loo is an author at University of California, San Francisco specializing in medicine, tumor immunity, and oncology.

ORCID

Top concepts

Publications per year

2009–2018

8

Publications

8

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

Kevin C. Barry, Joy Hsu, Miranda L. Broz et al. · Nature Medicine · 2018 · 973 citations

, , +14

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

Paul C. Tumeh, Matthew D. Hellmann, Omid Hamid et al. · Cancer Immunology Research · 2017 · 543 citations · Full text

Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma

Adil Daud, Kimberly Loo, Mariela Pauli et al. · Journal of Clinical Investigation · 2016 · 515 citations · Full text

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

Adi Nosrati, Katy K. Tsai, Simone M. Goldinger et al. · British Journal of Cancer · 2017 · 128 citations · Full text

Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy

Kimberly Loo, Katy K. Tsai, Kelly M. Mahuron et al. · JCI Insight · 2017 · 78 citations · Full text

1–5 of 8